RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
This study is currently recruiting participants.
Verified February 2013 by Dana-Farber Cancer Institute
Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Massachusetts General Hospital
M.D. Anderson Cancer Center
Mount Sinai Hospital, New York
Novartis
Information provided by (Responsible Party):
Jochen Lorch, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00936858
First received: July 9, 2009
Last updated: February 20, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | June 2014 (Final data collection date for primary outcome measure) |